Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/26 16:05 | 11/16/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Cho Dennis | CA | O | See Rema | 6 | S | -2,819 | 154.46 | 0 | -18 | 87 | D | |||||||||||||||
11/18/26 16:05 | 11/16/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Finn Patrick John | CA | O | P,COO | 5 | S | -7,391 | 156.19 | 0 | -47 | 239 | D | |||||||||||||||
11/18/26 16:05 | 11/16/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Green Paula | CA | O | SVP of H | 7 | S | -2,835 | 73.89 | 0 | -38 | 128 | D | |||||||||||||||
11/18/26 16:05 | 11/16/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Leproust Emily M. | CA | DO | CEO | 10 | S.dm | -77,339 | 158.32 | 0 | -489 | 812 | D | |||||||||||||||
11/18/26 16:05 | 11/16/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Werner Robert F. | CA | O | Chief Ac | 5 | S.m | -712 | 141.64 | 0 | -5 | 53 | D | |||||||||||||||
11/18/26 16:05 | 11/16/26 | TWST | Health | BioPrd | Biological Products, (No Diag | Laponis Adam | CA | O | CFO | 4 | S | -2,839 | 150.68 | 0 | -19 | 126 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |